362 related articles for article (PubMed ID: 31052253)
21. In Silico Approaches for TRP Channel Modulation.
Nikolaeva Koleva M; Fernandez-Ballester G
Methods Mol Biol; 2019; 1987():187-206. PubMed ID: 31028681
[TBL] [Abstract][Full Text] [Related]
22. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
23. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
Tripathi N; Goshisht MK; Sahu SK; Arora C
Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
[TBL] [Abstract][Full Text] [Related]
24. Exploring the potential of global protein-protein docking: an overview and critical assessment of current programs for automatic ab initio docking.
Huang SY
Drug Discov Today; 2015 Aug; 20(8):969-77. PubMed ID: 25801181
[TBL] [Abstract][Full Text] [Related]
25. Key Topics in Molecular Docking for Drug Design.
Torres PHM; Sodero ACR; Jofily P; Silva-Jr FP
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540192
[TBL] [Abstract][Full Text] [Related]
26. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
27. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
28. Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method.
Wu Z; Jiang D; Hsieh CY; Chen G; Liao B; Cao D; Hou T
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866354
[TBL] [Abstract][Full Text] [Related]
29. Mathematical and Computational Techniques for Drug Discovery: Promises and Developments.
Balasubramanian K
Curr Top Med Chem; 2018; 18(32):2774-2799. PubMed ID: 30747069
[TBL] [Abstract][Full Text] [Related]
30. Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.
Ooms F
Curr Med Chem; 2000 Feb; 7(2):141-58. PubMed ID: 10637360
[TBL] [Abstract][Full Text] [Related]
31. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
32. From bench to bedside, via desktop. Recent advances in the application of cutting-edge in silico tools in the research of drugs targeting bromodomain modules.
Myrianthopoulos V; Mikros E
Biochem Pharmacol; 2019 Jan; 159():40-51. PubMed ID: 30414936
[TBL] [Abstract][Full Text] [Related]
33. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Biomed Res Int; 2021; 2021():8853056. PubMed ID: 34258282
[TBL] [Abstract][Full Text] [Related]
34. Computer aided drug discovery review for infectious diseases with case study of anti-Chagas project.
Yasuo N; Ishida T; Sekijima M
Parasitol Int; 2021 Aug; 83():102366. PubMed ID: 33915269
[TBL] [Abstract][Full Text] [Related]
35. Software Infrastructure for Computer-aided Drug Discovery and Development, a Practical Example with Guidelines.
Moretti L; Sartori L
Mol Inform; 2016 Sep; 35(8-9):382-90. PubMed ID: 27546042
[TBL] [Abstract][Full Text] [Related]
36. Applications of Molecular Simulation in the Discovery of Antituberculosis Drugs: A Review.
Hu JP; Wu ZX; Xie T; Liu XY; Yan X; Sun X; Liu W; Liang L; He G; Gan Y; Gou XJ; Shi Z; Zou Q; Wan H; Shi HB; Chang S
Protein Pept Lett; 2019; 26(9):648-663. PubMed ID: 31218945
[TBL] [Abstract][Full Text] [Related]
37. Structure-based drug design: docking and scoring.
Kroemer RT
Curr Protein Pept Sci; 2007 Aug; 8(4):312-28. PubMed ID: 17696866
[TBL] [Abstract][Full Text] [Related]
38. Metal-organic frameworks: a rapidly growing class of versatile nanoporous materials.
Meek ST; Greathouse JA; Allendorf MD
Adv Mater; 2011 Jan; 23(2):249-67. PubMed ID: 20972981
[TBL] [Abstract][Full Text] [Related]
39. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
Gioia D; Bertazzo M; Recanatini M; Masetti M; Cavalli A
Molecules; 2017 Nov; 22(11):. PubMed ID: 29165360
[TBL] [Abstract][Full Text] [Related]
40. Is high performance computing a requirement for novel drug discovery and how will this impact academic efforts?
Puertas-Martín S; Banegas-Luna AJ; Paredes-Ramos M; Redondo JL; Ortigosa PM; Brovarets' OO; Pérez-Sánchez H
Expert Opin Drug Discov; 2020 Sep; 15(9):981-986. PubMed ID: 32345062
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
